Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALX006 for Postsurgical Pain Management in Bunionectomy
NCT07574385Phase 2Recruiting
- Sponsor
- Rebel Medicine
- Start
- Mar 2026
- Primary completion
- Aug 2026
- Modality
- Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ALX006 in Persistent postsurgical pain (PPSP), sponsored by Rebel Medicine. Started Mar 2026; status: recruiting.
02
Drugs
ALX006
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT07574385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07574385.